The cannabinoid receptor type two is a therapeutic target for muscular dystrophy cardiomyopathy.
22 April 2018 (08:30 - 16:30)
Organised by: 

Abstract
About the speaker

Monzino Cardiology Centre, Milan (Italy)
24 More presentations in this session
Access the full session
The Event
Frontiers in CardioVascular Biology 2018
22 April 2018
08:30 CET
